×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
ANEXA I REZUMATUL CARACTERISTICILOR PRODUSULUI · pasaj hepatic, mediată de enzima CYP3A4. Se recomandă precauţie la administrarea concomitentă cu inhibitori puternici ai CYP3A4
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form